0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Children Respiratory Syncytial Virus (RSV) Testing Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-34S10125
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Children Respiratory Syncytial Virus RSV Testing Market Research Report 2022
BUY CHAPTERS

Global Children Respiratory Syncytial Virus (RSV) Testing Market Research Report 2025

Code: QYRE-Auto-34S10125
Report
March 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Children Respiratory Syncytial Virus (RSV) Testing Market Size

The global market for Children Respiratory Syncytial Virus (RSV) Testing was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 212 million by 2031, growing at a CAGR of 9.7% during the forecast period.

Children Respiratory Syncytial Virus (RSV) Testing Market

Children Respiratory Syncytial Virus (RSV) Testing Market

Children Respiratory Syncytial Virus (RSV) testing refers to the process of diagnosing respiratory syncytial virus infection in children. RSV is a common viral infection that affects the respiratory system, particularly in infants and young children. RSV testing helps to identify the presence of the virus in a child"s respiratory samples, aiding in early diagnosis and appropriate management of the infection.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China"s birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children"s consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children"s Industry shows that in 80% of families in China, children"s expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
This report aims to provide a comprehensive presentation of the global market for Children Respiratory Syncytial Virus (RSV) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Respiratory Syncytial Virus (RSV) Testing.
The Children Respiratory Syncytial Virus (RSV) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children Respiratory Syncytial Virus (RSV) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Children Respiratory Syncytial Virus (RSV) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Children Respiratory Syncytial Virus (RSV) Testing Market Report

Report Metric Details
Report Name Children Respiratory Syncytial Virus (RSV) Testing Market
Accounted market size in year US$ 112 million
Forecasted market size in 2031 US$ 212 million
CAGR 9.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Testing Services
  • Testing Kits
  • Others
Segment by Application
  • Hospitals
  • POCT
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, OPERON, Laboratory Corporation of America, BioMerieux, Sekisui Diagnostics, Response Biomedical, ARUP Laboratories, DiaSorin (Focus Diagnostics), Avellino, Becton, Dickinson, and Company, Novartis AG, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., BIOMÉRIEUX, DiaSorin S.p.A., Merck KGaA, Coris BioConcept, Siemens Healthcare S.A., Quest Diagnostics Incorporated
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Children Respiratory Syncytial Virus (RSV) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Children Respiratory Syncytial Virus (RSV) Testing Market growing?

Ans: The Children Respiratory Syncytial Virus (RSV) Testing Market witnessing a CAGR of 9.7% during the forecast period 2025-2031.

What is the Children Respiratory Syncytial Virus (RSV) Testing Market size in 2031?

Ans: The Children Respiratory Syncytial Virus (RSV) Testing Market size in 2031 will be US$ 212 million.

Who are the main players in the Children Respiratory Syncytial Virus (RSV) Testing Market report?

Ans: The main players in the Children Respiratory Syncytial Virus (RSV) Testing Market are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, OPERON, Laboratory Corporation of America, BioMerieux, Sekisui Diagnostics, Response Biomedical, ARUP Laboratories, DiaSorin (Focus Diagnostics), Avellino, Becton, Dickinson, and Company, Novartis AG, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., BIOMÉRIEUX, DiaSorin S.p.A., Merck KGaA, Coris BioConcept, Siemens Healthcare S.A., Quest Diagnostics Incorporated

What are the Application segmentation covered in the Children Respiratory Syncytial Virus (RSV) Testing Market report?

Ans: The Applications covered in the Children Respiratory Syncytial Virus (RSV) Testing Market report are Hospitals, POCT, Others

What are the Type segmentation covered in the Children Respiratory Syncytial Virus (RSV) Testing Market report?

Ans: The Types covered in the Children Respiratory Syncytial Virus (RSV) Testing Market report are Testing Services, Testing Kits, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Testing Services
1.2.3 Testing Kits
1.2.4 Others
1.3 Market by Application
1.3.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Perspective (2020-2031)
2.2 Global Children Respiratory Syncytial Virus (RSV) Testing Growth Trends by Region
2.2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Region (2020-2025)
2.2.3 Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Region (2026-2031)
2.3 Children Respiratory Syncytial Virus (RSV) Testing Market Dynamics
2.3.1 Children Respiratory Syncytial Virus (RSV) Testing Industry Trends
2.3.2 Children Respiratory Syncytial Virus (RSV) Testing Market Drivers
2.3.3 Children Respiratory Syncytial Virus (RSV) Testing Market Challenges
2.3.4 Children Respiratory Syncytial Virus (RSV) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Revenue
3.1.1 Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Revenue (2020-2025)
3.1.2 Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Players (2020-2025)
3.2 Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Children Respiratory Syncytial Virus (RSV) Testing Revenue
3.4 Global Children Respiratory Syncytial Virus (RSV) Testing Market Concentration Ratio
3.4.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Children Respiratory Syncytial Virus (RSV) Testing Revenue in 2024
3.5 Global Key Players of Children Respiratory Syncytial Virus (RSV) Testing Head office and Area Served
3.6 Global Key Players of Children Respiratory Syncytial Virus (RSV) Testing, Product and Application
3.7 Global Key Players of Children Respiratory Syncytial Virus (RSV) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Type
4.1 Global Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Type (2020-2025)
4.2 Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Type (2026-2031)
5 Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Application
5.1 Global Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Application (2020-2025)
5.2 Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size (2020-2031)
6.2 North America Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025)
6.4 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size (2020-2031)
7.2 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025)
7.4 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size (2020-2031)
8.2 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size (2020-2031)
9.2 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025)
9.4 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size (2020-2031)
10.2 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.1.4 BD Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.1.5 BD Recent Development
11.2 Abbot (Alere)
11.2.1 Abbot (Alere) Company Details
11.2.2 Abbot (Alere) Business Overview
11.2.3 Abbot (Alere) Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.2.4 Abbot (Alere) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.2.5 Abbot (Alere) Recent Development
11.3 Quidel
11.3.1 Quidel Company Details
11.3.2 Quidel Business Overview
11.3.3 Quidel Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.3.4 Quidel Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.3.5 Quidel Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.4.4 Roche Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.5.4 Thermo Fisher Scientific Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Details
11.6.2 Meridian Bioscience Business Overview
11.6.3 Meridian Bioscience Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.6.4 Meridian Bioscience Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.6.5 Meridian Bioscience Recent Development
11.7 OPERON
11.7.1 OPERON Company Details
11.7.2 OPERON Business Overview
11.7.3 OPERON Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.7.4 OPERON Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.7.5 OPERON Recent Development
11.8 Laboratory Corporation of America
11.8.1 Laboratory Corporation of America Company Details
11.8.2 Laboratory Corporation of America Business Overview
11.8.3 Laboratory Corporation of America Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.8.4 Laboratory Corporation of America Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.8.5 Laboratory Corporation of America Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.9.4 BioMerieux Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.10.4 Sekisui Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.11.4 Response Biomedical Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.11.5 Response Biomedical Recent Development
11.12 ARUP Laboratories
11.12.1 ARUP Laboratories Company Details
11.12.2 ARUP Laboratories Business Overview
11.12.3 ARUP Laboratories Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.12.4 ARUP Laboratories Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.12.5 ARUP Laboratories Recent Development
11.13 DiaSorin (Focus Diagnostics)
11.13.1 DiaSorin (Focus Diagnostics) Company Details
11.13.2 DiaSorin (Focus Diagnostics) Business Overview
11.13.3 DiaSorin (Focus Diagnostics) Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.13.4 DiaSorin (Focus Diagnostics) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.13.5 DiaSorin (Focus Diagnostics) Recent Development
11.14 Avellino
11.14.1 Avellino Company Details
11.14.2 Avellino Business Overview
11.14.3 Avellino Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.14.4 Avellino Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.14.5 Avellino Recent Development
11.15 Becton, Dickinson, and Company
11.15.1 Becton, Dickinson, and Company Company Details
11.15.2 Becton, Dickinson, and Company Business Overview
11.15.3 Becton, Dickinson, and Company Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.15.4 Becton, Dickinson, and Company Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.15.5 Becton, Dickinson, and Company Recent Development
11.16 Novartis AG
11.16.1 Novartis AG Company Details
11.16.2 Novartis AG Business Overview
11.16.3 Novartis AG Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.16.4 Novartis AG Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.16.5 Novartis AG Recent Development
11.17 Ortho Clinical Diagnostics
11.17.1 Ortho Clinical Diagnostics Company Details
11.17.2 Ortho Clinical Diagnostics Business Overview
11.17.3 Ortho Clinical Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.17.4 Ortho Clinical Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.17.5 Ortho Clinical Diagnostics Recent Development
11.18 Bio-Rad Laboratories, Inc.
11.18.1 Bio-Rad Laboratories, Inc. Company Details
11.18.2 Bio-Rad Laboratories, Inc. Business Overview
11.18.3 Bio-Rad Laboratories, Inc. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.18.4 Bio-Rad Laboratories, Inc. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.18.5 Bio-Rad Laboratories, Inc. Recent Development
11.19 F. Hoffmann-La Roche Ltd.
11.19.1 F. Hoffmann-La Roche Ltd. Company Details
11.19.2 F. Hoffmann-La Roche Ltd. Business Overview
11.19.3 F. Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.19.4 F. Hoffmann-La Roche Ltd. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.19.5 F. Hoffmann-La Roche Ltd. Recent Development
11.20 BIOMÉRIEUX
11.20.1 BIOMÉRIEUX Company Details
11.20.2 BIOMÉRIEUX Business Overview
11.20.3 BIOMÉRIEUX Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.20.4 BIOMÉRIEUX Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.20.5 BIOMÉRIEUX Recent Development
11.21 DiaSorin S.p.A.
11.21.1 DiaSorin S.p.A. Company Details
11.21.2 DiaSorin S.p.A. Business Overview
11.21.3 DiaSorin S.p.A. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.21.4 DiaSorin S.p.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.21.5 DiaSorin S.p.A. Recent Development
11.22 Merck KGaA
11.22.1 Merck KGaA Company Details
11.22.2 Merck KGaA Business Overview
11.22.3 Merck KGaA Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.22.4 Merck KGaA Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.22.5 Merck KGaA Recent Development
11.23 Coris BioConcept
11.23.1 Coris BioConcept Company Details
11.23.2 Coris BioConcept Business Overview
11.23.3 Coris BioConcept Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.23.4 Coris BioConcept Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.23.5 Coris BioConcept Recent Development
11.24 Siemens Healthcare S.A.
11.24.1 Siemens Healthcare S.A. Company Details
11.24.2 Siemens Healthcare S.A. Business Overview
11.24.3 Siemens Healthcare S.A. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.24.4 Siemens Healthcare S.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.24.5 Siemens Healthcare S.A. Recent Development
11.25 Quest Diagnostics Incorporated
11.25.1 Quest Diagnostics Incorporated Company Details
11.25.2 Quest Diagnostics Incorporated Business Overview
11.25.3 Quest Diagnostics Incorporated Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.25.4 Quest Diagnostics Incorporated Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
11.25.5 Quest Diagnostics Incorporated Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Testing Services
 Table 3. Key Players of Testing Kits
 Table 4. Key Players of Others
 Table 5. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region (2020-2025)
 Table 9. Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region (2026-2031)
 Table 11. Children Respiratory Syncytial Virus (RSV) Testing Market Trends
 Table 12. Children Respiratory Syncytial Virus (RSV) Testing Market Drivers
 Table 13. Children Respiratory Syncytial Virus (RSV) Testing Market Challenges
 Table 14. Children Respiratory Syncytial Virus (RSV) Testing Market Restraints
 Table 15. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Players (2020-2025)
 Table 17. Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Respiratory Syncytial Virus (RSV) Testing as of 2024)
 Table 18. Ranking of Global Top Children Respiratory Syncytial Virus (RSV) Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Children Respiratory Syncytial Virus (RSV) Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Children Respiratory Syncytial Virus (RSV) Testing, Headquarters and Area Served
 Table 21. Global Key Players of Children Respiratory Syncytial Virus (RSV) Testing, Product and Application
 Table 22. Global Key Players of Children Respiratory Syncytial Virus (RSV) Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. BD Company Details
 Table 48. BD Business Overview
 Table 49. BD Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 50. BD Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 51. BD Recent Development
 Table 52. Abbot (Alere) Company Details
 Table 53. Abbot (Alere) Business Overview
 Table 54. Abbot (Alere) Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 55. Abbot (Alere) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 56. Abbot (Alere) Recent Development
 Table 57. Quidel Company Details
 Table 58. Quidel Business Overview
 Table 59. Quidel Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 60. Quidel Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 61. Quidel Recent Development
 Table 62. Roche Company Details
 Table 63. Roche Business Overview
 Table 64. Roche Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 65. Roche Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 66. Roche Recent Development
 Table 67. Thermo Fisher Scientific Company Details
 Table 68. Thermo Fisher Scientific Business Overview
 Table 69. Thermo Fisher Scientific Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 70. Thermo Fisher Scientific Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 71. Thermo Fisher Scientific Recent Development
 Table 72. Meridian Bioscience Company Details
 Table 73. Meridian Bioscience Business Overview
 Table 74. Meridian Bioscience Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 75. Meridian Bioscience Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 76. Meridian Bioscience Recent Development
 Table 77. OPERON Company Details
 Table 78. OPERON Business Overview
 Table 79. OPERON Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 80. OPERON Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 81. OPERON Recent Development
 Table 82. Laboratory Corporation of America Company Details
 Table 83. Laboratory Corporation of America Business Overview
 Table 84. Laboratory Corporation of America Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 85. Laboratory Corporation of America Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 86. Laboratory Corporation of America Recent Development
 Table 87. BioMerieux Company Details
 Table 88. BioMerieux Business Overview
 Table 89. BioMerieux Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 90. BioMerieux Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 91. BioMerieux Recent Development
 Table 92. Sekisui Diagnostics Company Details
 Table 93. Sekisui Diagnostics Business Overview
 Table 94. Sekisui Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 95. Sekisui Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 96. Sekisui Diagnostics Recent Development
 Table 97. Response Biomedical Company Details
 Table 98. Response Biomedical Business Overview
 Table 99. Response Biomedical Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 100. Response Biomedical Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 101. Response Biomedical Recent Development
 Table 102. ARUP Laboratories Company Details
 Table 103. ARUP Laboratories Business Overview
 Table 104. ARUP Laboratories Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 105. ARUP Laboratories Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 106. ARUP Laboratories Recent Development
 Table 107. DiaSorin (Focus Diagnostics) Company Details
 Table 108. DiaSorin (Focus Diagnostics) Business Overview
 Table 109. DiaSorin (Focus Diagnostics) Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 110. DiaSorin (Focus Diagnostics) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 111. DiaSorin (Focus Diagnostics) Recent Development
 Table 112. Avellino Company Details
 Table 113. Avellino Business Overview
 Table 114. Avellino Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 115. Avellino Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 116. Avellino Recent Development
 Table 117. Becton, Dickinson, and Company Company Details
 Table 118. Becton, Dickinson, and Company Business Overview
 Table 119. Becton, Dickinson, and Company Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 120. Becton, Dickinson, and Company Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 121. Becton, Dickinson, and Company Recent Development
 Table 122. Novartis AG Company Details
 Table 123. Novartis AG Business Overview
 Table 124. Novartis AG Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 125. Novartis AG Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 126. Novartis AG Recent Development
 Table 127. Ortho Clinical Diagnostics Company Details
 Table 128. Ortho Clinical Diagnostics Business Overview
 Table 129. Ortho Clinical Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 130. Ortho Clinical Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 131. Ortho Clinical Diagnostics Recent Development
 Table 132. Bio-Rad Laboratories, Inc. Company Details
 Table 133. Bio-Rad Laboratories, Inc. Business Overview
 Table 134. Bio-Rad Laboratories, Inc. Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 135. Bio-Rad Laboratories, Inc. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 136. Bio-Rad Laboratories, Inc. Recent Development
 Table 137. F. Hoffmann-La Roche Ltd. Company Details
 Table 138. F. Hoffmann-La Roche Ltd. Business Overview
 Table 139. F. Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 140. F. Hoffmann-La Roche Ltd. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 141. F. Hoffmann-La Roche Ltd. Recent Development
 Table 142. BIOMÉRIEUX Company Details
 Table 143. BIOMÉRIEUX Business Overview
 Table 144. BIOMÉRIEUX Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 145. BIOMÉRIEUX Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 146. BIOMÉRIEUX Recent Development
 Table 147. DiaSorin S.p.A. Company Details
 Table 148. DiaSorin S.p.A. Business Overview
 Table 149. DiaSorin S.p.A. Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 150. DiaSorin S.p.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 151. DiaSorin S.p.A. Recent Development
 Table 152. Merck KGaA Company Details
 Table 153. Merck KGaA Business Overview
 Table 154. Merck KGaA Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 155. Merck KGaA Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 156. Merck KGaA Recent Development
 Table 157. Coris BioConcept Company Details
 Table 158. Coris BioConcept Business Overview
 Table 159. Coris BioConcept Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 160. Coris BioConcept Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 161. Coris BioConcept Recent Development
 Table 162. Siemens Healthcare S.A. Company Details
 Table 163. Siemens Healthcare S.A. Business Overview
 Table 164. Siemens Healthcare S.A. Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 165. Siemens Healthcare S.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 166. Siemens Healthcare S.A. Recent Development
 Table 167. Quest Diagnostics Incorporated Company Details
 Table 168. Quest Diagnostics Incorporated Business Overview
 Table 169. Quest Diagnostics Incorporated Children Respiratory Syncytial Virus (RSV) Testing Product
 Table 170. Quest Diagnostics Incorporated Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025) & (US$ Million)
 Table 171. Quest Diagnostics Incorporated Recent Development
 Table 172. Research Programs/Design for This Report
 Table 173. Key Data Information from Secondary Sources
 Table 174. Key Data Information from Primary Sources
 Table 175. Authors List of This Report


List of Figures
 Figure 1. Children Respiratory Syncytial Virus (RSV) Testing Picture
 Figure 2. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type: 2024 VS 2031
 Figure 4. Testing Services Features
 Figure 5. Testing Kits Features
 Figure 6. Others Features
 Figure 7. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. POCT Case Studies
 Figure 11. Others Case Studies
 Figure 12. Children Respiratory Syncytial Virus (RSV) Testing Report Years Considered
 Figure 13. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Players in 2024
 Figure 17. Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Respiratory Syncytial Virus (RSV) Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Children Respiratory Syncytial Virus (RSV) Testing Revenue in 2024
 Figure 19. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2020-2031)
 Figure 21. United States Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2020-2031)
 Figure 25. Germany Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region (2020-2031)
 Figure 33. China Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. BD Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 49. Abbot (Alere) Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 50. Quidel Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 51. Roche Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 53. Meridian Bioscience Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 54. OPERON Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 55. Laboratory Corporation of America Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 56. BioMerieux Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 57. Sekisui Diagnostics Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 58. Response Biomedical Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 59. ARUP Laboratories Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 60. DiaSorin (Focus Diagnostics) Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 61. Avellino Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 62. Becton, Dickinson, and Company Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 63. Novartis AG Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 64. Ortho Clinical Diagnostics Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 65. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 66. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 67. BIOMÉRIEUX Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 68. DiaSorin S.p.A. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 69. Merck KGaA Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 70. Coris BioConcept Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 71. Siemens Healthcare S.A. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 72. Quest Diagnostics Incorporated Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart